Canada markets closed

Achilles Therapeutics plc (ACHL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.7600-0.0210 (-2.69%)
At close: 04:00PM EDT
0.7600 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
58,246
58,246
57,263
42,224
22,629
Selling General and Administrative
17,009
17,009
21,120
21,971
11,098
Total Operating Expenses
75,255
75,255
78,383
64,195
33,727
Operating Income or Loss
-75,255
-75,255
-78,383
-64,195
-33,727
Total Other Income/Expenses Net
6,081
6,081
7,318
3,133
531
Income Before Tax
-69,174
-69,174
-71,065
-61,062
-33,196
Income Tax Expense
491
491
111
37
3
Income from Continuing Operations
-69,665
-69,665
-71,176
-61,099
-33,199
Net Income
-69,665
-69,665
-71,176
-61,099
-33,199
Net Income available to common shareholders
-69,665
-69,665
-71,176
-61,099
-33,199
Basic EPS
-1.90
-1.74
-1.82
-2.13
-0.82
Diluted EPS
-1.90
-1.74
-1.82
-2.13
-0.82
Basic Average Shares
39,737
39,973
39,140
28,655
40,622
Diluted Average Shares
39,737
39,973
39,140
28,655
40,622